Fluvoxamine Maleate Capsule, Extended Release
Product Images NDC 0228-2849

Product Visual Gallery

This gallery contains 7 technical images submitted to the FDA as part of the official labeling for Fluvoxamine Maleate (NDC 0228-2849). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Actavis Pharma, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Ebfb06fd-figure-01 (Image 1)

FDA Label Image

Ebfb06fd-figure-02 (Image 2)

FDA Label Image

Ebfb06fd-figure-03 (Image 3)

FDA Label Image

Ebfb06fd-figure-04 (Image 4)

FDA Label Image

Ebfb06fd-figure-05 (Image 5)

FDA Label Image

1 (Image 6)

This is a description of a medication named Fluvoxamine Maleate, which comes in the form of extended-release capsules of 100mg. The pharmacist is asked to provide the patients with a Medication Guide. The capsules should not be chewed or crushed and should be stored at room temperature. The manufacturing company is Adams Elizabeth and the medicine is only available on prescription. No information is given about the use of the medicine or its indications.*

FDA Label Image

1 (Image 7)

This is a description of a medication packaging for Fioramine alese S5. The medication is in the form of extended-release capsules and comes in a container that has a once-a-day dosage. The prescription information is provided on the container label. The medication is not to be crushed or chewed. The medication should be stored at a temperature of 25°C with no exposure to excursions. The package contains 30 capsules and comes with a medication guide for each patient. The manufacturer is Embeniic and the distributor is Actavis.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.